Logo image of AKU

AKUMIN INC (AKU) Stock Fundamental Analysis

NASDAQ:AKU - Nasdaq - US01021X1000 - Common Stock - Currency: USD

0.2887  -0.06 (-17.87%)

After market: 0.2875 0 (-0.42%)

Fundamental Rating

3

Overall AKU gets a fundamental rating of 3 out of 10. We evaluated AKU against 102 industry peers in the Health Care Providers & Services industry. AKU has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AKU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AKU has reported negative net income.
In the past year AKU had a positive cash flow from operations.
AKU had negative earnings in 4 of the past 5 years.
Each year in the past 5 years AKU had a positive operating cash flow.
AKU Yearly Net Income VS EBIT VS OCF VS FCFAKU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of AKU (-9.35%) is worse than 66.96% of its industry peers.
AKU's Return On Invested Capital of 2.58% is in line compared to the rest of the industry. AKU outperforms 53.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AKU is significantly below the industry average of 9.62%.
The last Return On Invested Capital (2.58%) for AKU is above the 3 year average (1.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROIC 2.58%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
AKU Yearly ROA, ROE, ROICAKU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 100 200 300

1.3 Margins

AKU has a Operating Margin of 6.78%. This is in the better half of the industry: AKU outperforms 72.17% of its industry peers.
In the last couple of years the Operating Margin of AKU has grown nicely.
With a Gross Margin value of 25.32%, AKU perfoms like the industry average, outperforming 49.57% of the companies in the same industry.
In the last couple of years the Gross Margin of AKU has declined.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 25.32%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
AKU Yearly Profit, Operating, Gross MarginsAKU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKU is destroying value.
AKU has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AKU is higher compared to a year ago.
AKU Yearly Shares OutstandingAKU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
AKU Yearly Total Debt VS Total AssetsAKU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

AKU has an Altman-Z score of 0.30. This is a bad value and indicates that AKU is not financially healthy and even has some risk of bankruptcy.
AKU has a worse Altman-Z score (0.30) than 66.96% of its industry peers.
The Debt to FCF ratio of AKU is 59.58, which is on the high side as it means it would take AKU, 59.58 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 59.58, AKU perfoms like the industry average, outperforming 46.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Altman-Z 0.3
ROIC/WACC0.59
WACC4.35%
AKU Yearly LT Debt VS Equity VS FCFAKU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

AKU has a Current Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AKU (1.09) is worse than 70.43% of its industry peers.
AKU has a Quick Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, AKU is doing worse than 61.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
AKU Yearly Current Assets VS Current LiabilitesAKU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for AKU have decreased strongly by -118.41% in the last year.
The Revenue has grown by 38.20% in the past year. This is a very strong growth!
Measured over the past years, AKU shows a very strong growth in Revenue. The Revenue has been growing by 59.26% on average per year.
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%

3.2 Future

Based on estimates for the next years, AKU will show a very strong growth in Earnings Per Share. The EPS will grow by 29.98% on average per year.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKU Yearly Revenue VS EstimatesAKU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AKU Yearly EPS VS EstimatesAKU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

AKU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AKU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKU Price Earnings VS Forward Price EarningsAKU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKU indicates a rather cheap valuation: AKU is cheaper than 81.74% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AKU is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.18
EV/EBITDA 8.75
AKU Per share dataAKU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

AKU's earnings are expected to grow with 29.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AKU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKUMIN INC

NASDAQ:AKU (10/25/2023, 8:00:00 PM)

After market: 0.2875 0 (-0.42%)

0.2887

-0.06 (-17.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-09 2023-08-09
Earnings (Next)11-07 2023-11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners15.75%
Ins Owner Change0%
Market Cap25.84M
Analysts45
Price Target0.92 (218.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-60.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.18
P/OCF 0.44
P/B N/A
P/tB N/A
EV/EBITDA 8.75
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)0.25
FCFY84.98%
OCF(TTM)0.66
OCFY229.66%
SpS8.39
BVpS-0.93
TBVpS-13.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROCE 3.26%
ROIC 2.58%
ROICexc 2.65%
ROICexgc 11.22%
OM 6.78%
PM (TTM) N/A
GM 25.32%
FCFM 2.92%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
ROICexc(3y)1.99%
ROICexc(5y)2.97%
ROICexgc(3y)6.74%
ROICexgc(5y)9.33%
ROCE(3y)2.39%
ROCE(5y)3.5%
ROICexcg growth 3Y33.83%
ROICexcg growth 5Y32.54%
ROICexc growth 3Y18.03%
ROICexc growth 5Y32.94%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Debt/EBITDA 8.69
Cap/Depr 38.76%
Cap/Sales 4.98%
Interest Coverage 0.76
Cash Conversion 40.27%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.3
F-Score4
WACC4.35%
ROIC/WACC0.59
Cap/Depr(3y)38.9%
Cap/Depr(5y)51.85%
Cap/Sales(3y)4.13%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y270.48%
EBIT growth 3Y64.54%
EBIT growth 5Y115.95%
EBIT Next Year262.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.58%
FCF growth 3Y436.48%
FCF growth 5YN/A
OCF growth 1Y59.77%
OCF growth 3Y121.33%
OCF growth 5Y94.79%